Market
Comprehensive analysis of Pfizer documents by major news outlet by mid-2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Publications from major news outlets such as The New York Times, The Washington Post, or Reuters
Story
U.S. Judge Orders FDA to Release More Pfizer COVID-19 Vaccine Trial Documents for Transparency
Dec 6, 2024, 09:24 PM
A U.S. District Judge Mark Pittman has ordered the FDA to release an additional million pages of documents from Pfizer's COVID-19 vaccine trials. This decision comes after the FDA's unsuccessful attempt to end a public records lawsuit, which sought transparency on the authorization of the vaccines. The court's order aims to provide greater public access to the data behind the vaccine's authorization, following previous efforts to expedite the release of such documents. The documents in question were initially sought to be hidden by the FDA, marking a significant win for transparency.
View original story
Similar markets
Mainstream Media • 25%
Pfizer • 25%
Government Agencies • 25%
Independent Researchers • 25%
0-25% • 25%
76-100% • 25%
51-75% • 25%
26-50% • 25%
Vaccine Safety • 25%
FDA's Handling • 25%
Data Transparency • 25%
Effectiveness of Vaccines • 25%
Legal challenges against FDA • 25%
Increased transparency and trust • 25%
Policy changes in vaccine approval • 25%
No significant impact • 25%
Increased trust in vaccines • 25%
Indifference • 25%
Increased demand for transparency • 25%
Decreased trust in vaccines • 25%
FDA • 25%
No major impact on any organization • 25%
Public Health Organizations • 25%
Pfizer • 25%
